Catherine A. Dennen

发表

Proposing a “Brain Health Checkup (BHC)” as a Global Potential “Standard of Care” to Overcome Reward Dysregulation in Primary Care Medicine: Coupling Genetic Risk Testing and Induction of “Dopamine Homeostasis”

David E. Smith, K. Blum, J. Cadet, 2022, International journal of environmental research and public health.

Precision Behavioral Management (PBM) and Cognitive Control as a Potential Therapeutic and Prophylactic Modality for Reward Deficiency Syndrome (RDS): Is There Enough Evidence?

Margaret A. Madigan, K. Blum, R. Badgaiyan, 2022, International journal of environmental research and public health.

Why haven't we solved the addiction crisis?

K. Blum, D. Barh, P. Thanos, 2022, Journal of the Neurological Sciences.

Statistical Validation of Risk Alleles in Genetic Addiction Risk Severity (GARS) Test: Early Identification of Risk for Alcohol Use Disorder (AUD) in 74,566 Case–Control Subjects

K. Blum, P. Thanos, R. Badgaiyan, 2022, Journal of personalized medicine.

Neurogenetic and Epigenetic Aspects of Cannabinoids

K. Blum, P. Thanos, R. Badgaiyan, 2022, Epigenomes.

Researching Mitigation of Alcohol Binge Drinking in Polydrug Abuse: KCNK13 and RASGRF2 Gene(s) Risk Polymorphisms Coupled with Genetic Addiction Risk Severity (GARS) Guiding Precision Pro-Dopamine Regulation

K. Blum, M. Febo, P. Thanos, 2022, Journal of personalized medicine.

Hypothesizing That Pediatric Autoimmune Neuropsychiatric Associated Streptococcal (PANDAS) Causes Rapid Onset of Reward Deficiency Syndrome (RDS) Behaviors and May Require Induction of “Dopamine Homeostasis”

K. Blum, P. Thanos, D. Baron, 2022, Open journal of immunology.

Should Reward Deficiency Syndrome (RDS) Be Considered an Umbrella Disorder for Mental Illness and Associated Genetic and Epigenetic Induced Dysregulation of Brain Reward Circuitry?

K. Blum, D. Barh, P. Thanos, 2022, Journal of personalized medicine.

Genetic Addiction Risk Severity Assessment Identifies Polymorphic Reward Genes as Antecedents to Reward Deficiency Syndrome (RDS) Hypodopaminergia’s Effect on Addictive and Non-Addictive Behaviors in a Nuclear Family

K. Blum, P. Thanos, R. Badgaiyan, 2022, Journal of personalized medicine.

Theorizing the Role of Dopaminergic Polymorphic Risk Alleles with Intermittent Explosive Disorder (IED), Violent/Aggressive Behavior and Addiction: Justification of Genetic Addiction Risk Severity (GARS) Testing

K. Blum, P. Thanos, R. Badgaiyan, 2022, Journal of personalized medicine.

Future Newborns with Opioid-Induced Neonatal Abstinence Syndrome (NAS) Could Be Assessed with the Genetic Addiction Risk Severity (GARS) Test and Potentially Treated Using Precision Amino-Acid Enkephalinase Inhibition Therapy (KB220) as a Frontline Modality Instead of Potent Opioids

K. Blum, D. Barh, P. Thanos, 2022, Journal of personalized medicine.

Genetic Addiction Risk and Psychological Profiling Analyses for “Preaddiction” Severity Index

K. Blum, D. Barh, P. Thanos, 2022, Journal of personalized medicine.

Offering a putative neurobiological “dopamine homeostatic” solution to overcome the perils of the reward deficiency syndrome pandemic: emergence of “precision behavioral management”

K. Blum, P. Thanos, R. Badgaiyan, 2022, Annals of translational medicine.

Positive Clinical Outcomes for Severe Reported Pain Using Robust Non-Addictive Home Electrotherapy—A Case-Series

K. Blum, D. Barh, P. Thanos, 2023, Journal of Personalized Medicine.

“Preaddiction” construct and reward deficiency syndrome: genetic link via dopaminergic dysregulation

K. Blum, P. Thanos, R. Badgaiyan, 2022, Annals of translational medicine.

Frequency of the Dopamine Receptor D3 (rs6280) vs. Opioid Receptor µ1 (rs1799971) Polymorphic Risk Alleles in Patients with Opioid Use Disorder: A Preponderance of Dopaminergic Mechanisms?

K. Blum, D. Baron, M. Gold, 2022, Biomedicines.

Personalized repetitive transcranial magnetic stimulation (prtms®) for post-traumatic stress disorder (ptsd) in military combat veterans

K. Blum, J. Cadet, J. Yesavage, 2023, Heliyon.

Preliminary Observations of Personalized Repetitive Magnetic Stimulation (PrTMS) Guided by EEG Spectra for Concussion

P. Thanos, D. Baron, Catherine A. Dennen, 2023, Brain sciences.

Metheamphetamine for Children: Are We Over or Under Dosing?

K. Blum, P. Thanos, R. Badgaiyan, 2023, Journal of addiction psychiatry.

Invited Expert Opinion- Bioinformatic and Limitation Directives to Help Adopt Genetic Addiction Risk Screening and Identify Preaddictive Reward Dysregulation: Required Analytic Evidence to Induce Dopamine Homeostatsis

P. Thanos, R. Badgaiyan, D. Baron, 2023, Medical research archives.

Addressing cortex dysregulation in youth through brain health check coaching and prophylactic brain development

Margaret A. Madigan, P. Thanos, R. Badgaiyan, 2024, INNOSC theranostics & pharmacological sciences.